Unfortunately, there are limited studies concerning the role of LAMA2 in brain tumors, although it has been postulated that this is an element of the differentiation niche of glioma initiating cells and considered responsible for therapeutic resistance and the recurrence of a subset of glial tumors [36]. Here, LAMA2 is linked to central nervous system cancer.